SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Trinity Biotech (TRIBY) -- Ignore unavailable to you. Want to Upgrade?


To: Decci who wrote (7863)1/23/1998 12:13:00 AM
From: milton  Read Replies (1) | Respond to of 14328
 
Decci
It's a puzzle to me, but triby is not a White House sex scandal, so it doesn't get the audience. Triby doesn't have the earnings coverage (or reporting) that we see in the frequent news announcements from other companies (see BIOI, for example). I am frustrated that triby's PR people don't address this. Nevertheless, triby's current growth (earnings, acquisitions, product expansions, and marketing alliances and expansions) all lead to the no-brain conclusion that triby will reward the patient. One difference with triby's past price performance, is that this growth curve began to show for the first time in 1997 and continues. The only way to make this easier is to leave the country and come back in 12 months to pick up the winnings. The MM's can't keep triby down forever. I hope you get rich on this one.